Insight Molecular Diagnostics (IMDX) Return on Capital Employed Growth (1y) (2017 - 2026)
Insight Molecular Diagnostics (IMDX) Return on Capital Employed Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | -17.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 42.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 732.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 44.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -18.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 42.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -1,014.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -251.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 21.00 |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 | -8,055.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8,055.00 |
| Dec 31, 2025 | -8,012.00 |
| Sep 30, 2025 | -9,485.00 |
| Jun 30, 2025 | -6,748.00 |
| Mar 31, 2025 | -8,776.00 |
| Dec 31, 2024 | -8,177.00 |
| Sep 30, 2024 | -1,209.00 |
| Jun 30, 2024 | -1,870.00 |
| Mar 31, 2024 | -3,425.00 |
| Dec 31, 2023 | -1,052.00 |
| Sep 30, 2023 | 86.00 |
| Jun 30, 2023 | 1,693.00 |
| Mar 31, 2023 | 3,627.00 |
| Dec 31, 2022 | 3,410.00 |
| Sep 30, 2022 | 30.00 |
| Jun 30, 2022 | -929.00 |
| Mar 31, 2022 | -792.00 |
| Dec 31, 2021 | 1,288.00 |
| Sep 30, 2021 | 3,178.00 |
| Jun 30, 2021 | 2,684.00 |